Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) EPS (Weighted Average and Diluted) (2022 - 2025)

Genelux has reported EPS (Weighted Average and Diluted) over the past 4 years, most recently at -$0.24 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.24 for Q4 2025, up 7.69% from a year ago — trailing twelve months through Dec 2025 was -$0.86 (up 10.42% YoY), and the annual figure for FY2025 was -$0.86, up 9.47%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.24 at Genelux, down from -$0.21 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for GNLX hit a ceiling of $0.49 in Q3 2022 and a floor of -$0.53 in Q1 2023.
  • Median EPS (Weighted Average and Diluted) over the past 4 years was -$0.22 (2023), compared with a mean of -$0.21.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 140.82% in 2023 and later surged 45.28% in 2024.
  • Genelux's EPS (Weighted Average and Diluted) stood at -$0.38 in 2022, then soared by 34.21% to -$0.25 in 2023, then fell by 4.0% to -$0.26 in 2024, then increased by 7.69% to -$0.24 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.24 (Q4 2025), -$0.21 (Q3 2025), and -$0.2 (Q2 2025) per Business Quant data.